Organovo Logo     Print Page | Close Window

Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the high-value drug profiling and therapeutic tissues markets
2018 Annual Report Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) - 0.05 (3.65%)
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $1.32 with a 52 week high of $2.48 and a 52 week low of $0.91.
Recent Investor News
Organovo Announces Release Date for Fiscal First-Quarter 2019 Financial Results
Organovo Reports Fiscal Fourth-Quarter and Full-Year 2018 Results; Company Announces Key Goals for Fiscal-Year 2019
Investor Events
Thursday, August 9, 2018 5:00 p.m. ET
Organovo Holdings, Inc. First Quarter Earnings Conference Call
Featured Reports
2018 Annual Report
2018 Proxy Statement
Latest Tweets